Gilead Sciences Inc
NASDAQ:GILD
Gilead Sciences Inc
NASDAQ:GILD
Price:
67.01 USD
-0.95%
Market Closed
Updated:
May 16, 2024
Gilead Sciences Inc
Income to Minority Interest
|
Gilead Sciences Inc
Income to Minority Interest Peer Comparison
Comparables:
ABBV
AMGN
MRNA
VRTX
REGN
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Income to Minority Interest
$26m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
54%
|
CAGR 10-Years
4%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Income to Minority Interest
-$10m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Moderna Inc
NASDAQ:MRNA
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gilead Sciences Inc's Income to Minority Interest?
Income to Minority Interest
26m
USD
26m
USD
Based on the financial report for Mar 31, 2024, Gilead Sciences Inc's Income to Minority Interest amounts to 26m USD.
What is Gilead Sciences Inc's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 10Y
4%
4%
Over the last year, the Income to Minority Interest growth was -42%. The average annual Income to Minority Interest growth rates for Gilead Sciences Inc have been -2% over the past three years , 54% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
